Z. Sheikh

In vivo measurement of the surface energy of human fingernail plates

S. Murdan, C. Poojary, D. R. Patel, 2012, International journal of cosmetic science.

Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.

M. Kassiou, T. Reekie, P. Young, 2021, European journal of pharmacology.

An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line.

P. Young, D. Traini, P. Bradbury, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Preliminary studies on phytochemicals and cytotoxic activity of methanolic rhizome extract of Hedychium coronarium

Z. Sheikh, P. R. Dash, Pritesh Ranjan Dash, 2015 .

In vitro interactions of aerosol formulations with human nasal epithelium using real-time monitoring of drug transport in a nasal mucosa-on-a-chip.

P. Young, H. Ong, A. Kourmatzis, 2022, Biosensors & bioelectronics.

Phytochemical and hypoglycemic screening of seeds and peel of nephelium longan fruits

Z. Sheikh, F. Ripa, M. Nesa, 2015 .

Phytochemical analysis, cytotoxic and in vitro antioxidant activity of erythrina variegate bark

Kamruzzaman, N. Khair, R. Akhter, 2016 .

Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.

P. Young, P. Spicer, D. Traini, 2022, International journal of pharmaceutics.

Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment?

P. Young, H. Ong, D. Traini, 2018 .

The development of a 3D-printed in vitro integrated oro-pharyngeal air–liquid interface cellular throat model for drug transport

L. Casettari, P. Young, H. Ong, 2023, Drug Delivery and Translational Research.

Development of Inhalable Spray Dried Nitrofurantoin Formulations for the Treatment of Emphysema

P. Young, H. Ong, D. Traini, 2022, Pharmaceutics.

Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis.

P. Young, D. Traini, P. Bradbury, 2021, International journal of pharmaceutics.